PremiumMRK

MRK: an overreaction to earnings?

The company published 2025 EPS guidance 2% below consensus due to lower-than-expected sales of the GARADASIL vaccine in China, and the stock fell by 11%.

By the SpyStocks desk · · 1 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Good intel travels.

Share this story

Millions of dollars in CALL options on Moderna

PremiumOption WhalesMRNA6h ago1 min read

Unusual mega dark pool transaction on the S&P 500

PremiumBreaking6h ago1 min read

Microsoft introduces new AI chips and their impact on the market

PremiumBreakingTSM12h ago1 min read